Functional testing plays central role in care of glaucoma patients

Article

Visual field testing can be frustrating for patients, but it should remain a core component of patient care because it provides essential information about glaucoma progression.

Key Points

Salt Lake City-Visual field testing (VFT) can be frustrating for patients, but it should remain a core component of patient care because it provides essential information about glaucoma progression, said Michael Chaglasian, OD, at Optometry's Meeting.

"As a bottom line," he continued, "identifying progression in glaucoma is difficult, and no single modality of evaluation should be used in isolation. Monitoring requires a combination of visual fields, structural analysis, and clinical and photographic assessment. Clinicians should become comfortable with all of these tools and know the strengths and limitations of the systems they are using in order to optimize individual patient care."

Currently, standard automated perimetry-white-on-white-remains the gold standard for VFT in glaucoma. Dr. Chaglasian recommended using threshold algorithms, noting he most frequently uses the 24-2 SITA-standard program (Humphrey Field Analyzer [HFA], Carl Zeiss Meditec). Programs with a similar test pattern and number of stimulus locations are available on instruments from other manufacturers.

In evaluating serial visual fields, clinicians must recognize that in eyes with early glaucomatous functional loss, fluctuation in the location of defects is not uncommon. Data on the repeatability of visual function testing from the large, randomized, controlled OHTS showed that 86% of abnormal and reliable fields were not confirmed on retesting.

Other data from OHTS showed that a visual field abnormality confirmed by three consecutive, reliable results offered greater specificity. Yet, some eyes with three abnormal tests still had a normal test on subsequent follow-up.

"This reminds us of the need to carefully evaluate any field abnormality and to be cautious about making a diagnosis just based on a single visual field for a patient," Dr. Chaglasian told Optometry Times.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
© 2025 MJH Life Sciences

All rights reserved.